Stock listing
NASDAQ:SCYX Scynexis, Inc. Stock
Home listing (NASDAQ) of Scynexis, Inc.
Follow Scynexis, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:SCYX
$3.77 USD -0.09 (-2.3%)
Close on Oct 30, 2026
- Day range
- $3.67 – $3.89 USDOct 30, 2026
- Volume
- 117,785 sharesOct 30, 2026
- Market cap
- $37.51M USDAt the close on Oct 30, 2026 · price × 9.95M shares outstanding
- 52-week range
- $3.53 – $9.12 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $1.30M USDMedian day 69,240 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:SCYX · Home | $3.77 USD | -0.09 (-2.3%) | 117,785 | $3.78 | $3.885 | $3.67 | $3.86 | Close on Oct 30, 2026 |
| LSE:0L49 | $3.84 USD | +0.04 (+1.1%) | 33 | $4.02 | $4.02 | $3.84 | $3.80 | Close on Oct 27, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:SCYX · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $3.77 | -0.09 | -2.3% | $3.78 | $3.885 | $3.67 | 117,785 | |
| $3.86 | -0.09 | -2.3% | $3.97 | $4.04 | $3.72 | 133,503 | |
| $3.95 | +0.15 | +3.9% | $3.77 | $3.95 | $3.77 | 53,870 | |
| $3.80 | -0.01 | -0.3% | $3.84 | $3.90 | $3.66 | 43,178 | |
| $3.81 | +0.025 | +0.7% | $3.78 | $3.90 | $3.78 | 64,008 | |
| $3.785 | -0.025 | -0.7% | $3.80 | $3.84 | $3.71 | 54,998 | |
| $3.81 | +0.025 | +0.7% | $3.75 | $3.91 | $3.75 | 39,077 | |
| $3.785 | -0.015 | -0.4% | $3.89 | $3.98 | $3.76 | 70,202 | |
| $3.80 | +0.14 | +3.8% | $3.66 | $3.90 | $3.66 | 54,621 | |
| $3.66 | -0.01 | -0.3% | $3.705 | $3.83 | $3.66 | 76,342 | |
| $3.67 | -0.24 | -6.1% | $3.87 | $3.88 | $3.535 | 189,485 | |
| $3.91 | -0.05 | -1.3% | $3.96 | $3.97 | $3.78 | 69,669 | |
| $3.96 | -0.03 | -0.8% | $4.00 | $4.08 | $3.90 | 44,601 | |
| $3.99 | -0.04 | -1.0% | $4.03 | $4.09 | $3.92 | 66,761 | |
| $4.03 | -0.05 | -1.2% | $4.05 | $4.15 | $4.00 | 68,005 | |
| $4.08 | -0.14 | -3.3% | $4.19 | $4.23 | $4.02 | 120,054 | |
| $4.22 | -0.56 | -11.7% | $4.70 | $4.75 | $4.11 | 344,328 | |
| $4.78 | -0.06 | -1.2% | $4.86 | $5.04 | $4.75 | 80,839 | |
| $4.84 | -0.19 | -3.8% | $5.10 | $5.29 | $4.79 | 163,949 | |
| $5.03 | -0.09 | -1.8% | $5.09 | $5.20 | $4.83 | 356,470 | |
| $5.12 | -0.25 | -4.7% | $5.32 | $5.51 | $5.09 | 132,401 | |
| $5.37 | +0.43 | +8.7% | $4.99 | $5.50 | $4.86 | 601,965 | |
| $4.94 | +0.28 | +6.0% | $4.65 | $5.025 | $4.56 | 311,609 | |
| $4.66 | +0.04 | +0.9% | $4.62 | $4.80 | $4.52 | 542,385 | |
| $4.62 | +0.23 | +5.2% | $4.60 | $5.14 | $4.45 | 7,784,229 | |
| $4.39 | -0.06 | -1.3% | $4.582 | $4.582 | $4.366 | 31,641 | |
| $4.45 | -0.185 | -4.0% | $4.58 | $4.81 | $4.415 | 38,016 | |
| $4.635 | -0.225 | -4.6% | $4.93 | $5.00 | $4.42 | 65,733 | |
| $4.86 | +0.46 | +10.5% | $4.47 | $4.94 | $4.36 | 167,832 | |
| $4.40 | -0.06 | -1.3% | $4.59 | $4.59 | $4.27 | 45,907 | |
| $4.46 | +0.01 | +0.2% | $4.49 | $4.695 | $4.41 | 68,811 | |
| $4.45 | +0.34 | +8.3% | $4.11 | $4.59 | $4.11 | 70,984 | |
| $4.11 | -0.28 | -6.4% | $4.43 | $4.533 | $4.08 | 102,800 | |
| $4.39 | -0.21 | -4.6% | $4.59 | $4.63 | $4.37 | 64,468 | |
| $4.60 | -0.24 | -5.0% | $4.84 | $4.97 | $4.572 | 47,613 | |
| $4.84 | +0.14 | +3.0% | $4.72 | $5.059 | $4.72 | 30,448 | |
| $4.70 | -0.21 | -4.3% | $4.82 | $4.97 | $4.63 | 47,344 | |
| $4.91 | -0.24 | -4.7% | $5.15 | $5.22 | $4.86 | 58,565 | |
| $5.15 | -0.15 | -2.8% | $5.30 | $5.35 | $5.15 | 33,070 | |
| $5.30 | -0.045 | -0.8% | $5.31 | $5.45 | $5.18 | 55,499 | |
| $5.345 | +0.125 | +2.4% | $5.03 | $5.37 | $5.03 | 33,719 | |
| $5.22 | +0.05 | +1.0% | $5.17 | $5.33 | $5.13 | 39,700 | |
| $5.17 | -0.06 | -1.1% | $5.33 | $5.34 | $5.11 | 76,079 | |
| $5.23 | -0.16 | -3.0% | $5.38 | $5.50 | $5.215 | 42,370 | |
| $5.39 | -0.13 | -2.4% | $5.56 | $5.70 | $5.35 | 56,835 | |
| $5.52 | -0.15 | -2.6% | $5.65 | $5.701 | $5.39 | 87,201 | |
| $5.67 | +0.48 | +9.2% | $5.20 | $6.09 | $5.10 | 220,638 | |
| $5.19 | -0.07 | -1.3% | $5.33 | $5.53 | $5.14 | 124,533 | |
| $5.26 | +0.16 | +3.1% | $5.15 | $5.33 | $5.00 | 123,945 | |
| $5.10 | -0.12 | -2.3% | $5.29 | $5.406 | $5.05 | 35,178 | |
| $5.22 | +0.07 | +1.4% | $5.16 | $5.28 | $5.102 | 24,698 | |
| $5.15 | +0.01 | +0.2% | $5.29 | $5.395 | $5.09 | 56,653 | |
| $5.14 | +0.05 | +1.0% | $5.05 | $5.20 | $5.04 | 37,965 | |
| $5.09 | -0.09 | -1.7% | $5.20 | $5.52 | $4.90 | 127,081 | |
| $5.18 | +0.06 | +1.2% | $5.17 | $5.35 | $4.99 | 101,462 | |
| $5.12 | +0.31 | +6.4% | $4.88 | $5.14 | $4.80 | 77,231 | |
| $4.81 | -0.025 | -0.5% | $4.80 | $4.92 | $4.71 | 38,453 | |
| $4.835 | -0.32 | -6.2% | $5.22 | $5.22 | $4.65 | 261,234 | |
| $5.155 | -0.085 | -1.6% | $5.21 | $5.30 | $5.05 | 51,599 | |
| $5.24 | +0.04 | +0.8% | $5.25 | $5.52 | $5.21 | 94,610 | |
| $5.20 | +0.04 | +0.8% | $5.30 | $5.42 | $5.135 | 67,651 | |
| $5.16 | -0.24 | -4.4% | $5.39 | $5.40 | $5.01 | 96,442 | |
| $5.40 | +0.33 | +6.5% | $5.11 | $5.54 | $5.02 | 178,399 | |
| $5.07 | +0.23 | +4.8% | $4.87 | $5.20 | $4.41 | 432,449 | |
| $4.84 | +1.11 | +29.8% | $3.60 | $4.95 | $3.60 | 3,184,532 | |
| $3.73 | -0.04 | -1.1% | $3.86 | $3.86 | $3.545 | 58,908 |
- Ticker
- NASDAQ:SCYX
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 29, 2026
SCYNEXIS to Participate in the 3rd Annual Guggenheim Healthcare Innovation Conference
Latest deck · October 2026
Investor Presentation (October 2026)
Investor deck · 23 slides
Calls
Replays
SCYNEXIS (NASDAQ:SCYX) Q3 2022 Earnings Call
Wed, Nov 09, 2022 · 7:30 AM ET
Watch TranscriptSCYNEXIS (NASDAQ:SCYX) Q2 2022 Earnings Call
Mon, Aug 15, 2022 · 8:30 AM ET
Watch TranscriptSCYNEXIS (NASDAQ:SCYX) Q1 2022 Earnings Call
Thu, May 12, 2022 · 8:30 AM ET
Watch Transcript
Latest news
SCYNEXIS to Participate in the 3rd Annual Guggenheim Healthcare Innovation Conference
Oct 29, 2026
Closed $3.86 (-2.3%) on Oct 29, 2026
SCYNEXIS Completes Phase 1 Study of Intravenous SCY-247, a Novel, Triterpenoid Antifungal in Development for Treatment and Prevention of Invasive Fungal Diseases
Oct 22, 2026
Closed $3.81 (+0.7%) on Oct 22, 2026
SCYNEXIS to Feature SCY-247 in a Pipeline Presentation at IDWeek
Oct 21, 2026
Closed $3.81 (+0.7%) on Oct 22, 2026
SCYNEXIS Announces Phase 1 Study Results for SCY-770, a Novel, Highly Selective, Oral Direct AMPK Activator for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Oct 6, 2026
Closed $4.84 (-3.8%) on Oct 6, 2026
SCYNEXIS Awarded BARDA Contract Providing Up to $214 Million in Non-Dilutive Funding for the Development of SCY-247
Sep 28, 2026
Closed $4.62 (+5.2%) on Sep 28, 2026
SCYNEXIS Appoints Seasoned Industry Veteran Steven K. Burke, M.D., to its Board of Directors
Sep 22, 2026
Closed $4.86 (+10.5%) on Sep 22, 2026
SCYNEXIS Appoints Todd Minga, M.D., as Senior Vice President, Research & Development
Sep 15, 2026
Closed $4.39 (-4.6%) on Sep 15, 2026
SCYNEXIS Announces Appointment of Sanjay Subramanian as Chief Financial Officer
Sep 10, 2026
Closed $4.70 (-4.3%) on Sep 10, 2026
SCYNEXIS to Participate in Upcoming Investor Conferences
Sep 1, 2026
Closed $5.17 (-1.1%) on Sep 1, 2026
SCYNEXIS Announces Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
Aug 25, 2026
Closed $5.67 (+9.2%) on Aug 26, 2026
Decks
Investor Presentation (October 2026)
Investor deck · 23 slides · October 2026
Investor Presentation (September 2026)
Investor deck · 19 slides · September 2026
Investor Presentation (March 2026)
Investor deck · 20 slides · Mar 31, 2026
Investor Presentation (September 2024)
Investor deck · 16 slides · Sep 10, 2024
Scynexis, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 26 in the last 12 months · 177 in all · newest Oct 29, 2026 · oldest 2019
- Calls
- 4 calls with a replay · 4 with a transcript · latest Nov 9, 2022
- Decks
- 13 decks · latest October 2026
Where Scynexis, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:SCYX · Home listing · This page | NASDAQ | United States | USD |
| LS Exchange:A2P9T4 | LS Exchange | Germany | EUR |
| gettex:135A | gettex | Germany | EUR |
| Lang & Schwarz:A2P9T4 | Lang & Schwarz | Germany | EUR |
| LSE:0L49 | LSE | United Kingdom | USD |
| BOATS:SCYX | BOATS | United States | USD |
| Frankfurt:135A | Frankfurt | Germany | EUR |
| Dusseldorf:135A | Dusseldorf | Germany | EUR |
| Munich:135A | Munich | Germany | EUR |
| Stuttgart:135A | Stuttgart | Germany | EUR |
| Tradegate:135A | Tradegate | Germany | EUR |
Log in to ask 6ix AI your own questions about Scynexis, Inc.